Note 3 - Revenue (Tables)

9 Months Ended

Sep. 30, 2021

Notes Tables

Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]

Nine Months Ended September 30, 2021
Outstanding at January 1, 2021	$	5,899
Increase (decrease) attributed to:
Transferred to receivables from contract assets recognized		(5,140	)
Product transferred over time		7,387
Outstanding at September 30, 2021	$	8,145

Disaggregation of Revenue [Table Text Block]

	Three Months Ended September 30, 2021
	Product/ Service Transferred Over Time		Product Transferred at Point in Time		Noncash Consideration		Total Net Sales by Market
Medical	$	13,762	$	2,933	$	282	$	16,977
Aerospace and Defense		2,883		144		65		3,092
Industrial		7,468		1,757		158		9,383
Total Net Sales	$	24,113	$	4,834	$	505	$	29,452

	Nine Months Ended September 30, 2021
	Product/ Service Transferred Over Time		Product Transferred at Point in Time		Noncash Consideration		Total Net Sales by Market
Medical	$	35,497	$	8,876	$	1,017	$	45,390
Aerospace and Defense		9,685		527		327		10,539
Industrial		20,385		4,832		560		25,777
Total Net Sales	$	65,567	$	14,235	$	1,904	$	81,706

	Three Months Ended September 30, 2020
	Product/ Service Transferred Over Time		Product Transferred at Point in Time		Noncash Consideration		Total Net Sales by Market
Medical	$	10,960	$	1,853	$	1,405	$	14,218
Aerospace and Defense		5,525		16		665		6,206
Industrial		4,527		791		620		5,938
Total Net Sales	$	21,012	$	2,660	$	2,690	$	26,362

	Nine Months Ended September 30, 2020
	Product/ Service Transferred Over Time		Product Transferred at Point in Time		Noncash Consideration		Total Net Sales by Market
Medical	$	35,835	$	4,454	$	2,464	$	42,753
Aerospace and Defense		14,160		396		953		15,509
Industrial		17,434		3,354		1,213		22,001
Total Net Sales	$	67,429	$	8,204	$	4,630	$	80,263